PRMT1 Is a novel regulator of epithelial-mesenchymal-transition in non-small cell lung cancer

Sreedevi Avasarala, Michelle Van Scoyk, Manoj Kumar Karuppusamy Rathinam, Sereke Zerayesus, Xiangmin Zhao, Wei Zhang, Melissa R. Pergande, Jeffrey A. Borgia, James DeGregori, J. David Port, Robert A. Winn, Rama Kamesh Bikkavilli*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

65 Scopus citations


Protein arginine methyl transferase 1 (PRMT1) was shown to be up-regulated in cancers and important for cancer cell proliferation. However, the role of PRMT1 in lung cancer progression and metastasis remains incompletely understood. In the present study, we show that PRMT1 is an important regulator of epithelial-mesenchymal transition (EMT), cancer cell migration, and invasion, which are essential processes during cancer progression, and metastasis. Additionally, we have identified Twist1, a basic helix-loop-helix transcription factor and a well-known E-cadherin repressor, as a novel PRMT1 substrate. Taken together, we show that PRMT1 is a novel regulator of EMT and arginine 34 (Arg-34) methylation of Twist1 as a unique "methyl arginine mark" for active E-cadherin repression. Therefore, targeting PRMT1-mediated Twist1 methylation might represent a novel strategy for developing new anti-invasive/anti-metastatic drugs. Moreover, methylated Twist1 (Arg-34), as such, could also emerge as a potential important biomarker for lung cancer.

Original languageEnglish (US)
Pages (from-to)13479-13489
Number of pages11
JournalJournal of Biological Chemistry
Issue number21
StatePublished - May 22 2015

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Fingerprint Dive into the research topics of 'PRMT1 Is a novel regulator of epithelial-mesenchymal-transition in non-small cell lung cancer'. Together they form a unique fingerprint.

Cite this